Jason Lazarou

5.6k citations
7 papers · 3.9k indexed · 2 hit papers · h-index 4
Topics
Pharmaceutical Practices and Patient Outcomes (3 papers)Pharmacovigilance and Adverse Drug Reactions (3 papers)Pharmaceutical studies and practices (2 papers)
Partner nations
CanadaUnited States

In The Last Decade

Jason Lazarou

5 papers receiving 3.6k citations

Hit Papers

Incidence of Adverse Drug Reactions in Hospitalized Patients19982026200720161998199910002.0k3.0k

Peers

Jason Lazarou
Comparison fields: 5 of 148
  • Toxicology 1.4k
  • Geriatrics and Gerontology 1.3k
  • Pediatrics, Perinatology and Child Health 1.1k
  • Pharmacology 870
  • Pharmacology 559
Replace Alasdair Breckenridge with:
Alasdair Breckenridge United Kingdom
B Kevin Park United Kingdom
Thomas Walley United Kingdom
Keith Farrar United Kingdom
Andrew Scott United Kingdom
Gianluca Trifirò Italy
I. Ralph Edwards Sweden
Staffan Hägg Sweden
Raymond G. Schlienger Switzerland
Hubert G.M. Leufkens Netherlands
Jason Lazarou relative to Alasdair Breckenridge United Kingdom Alasdair Breckenridge's profile →
Citations per field
00.5×1.5×
Alasdair Breckenridge · 1×
Citations per year

Countries citing papers authored by Jason Lazarou

Since Specialization
Citations

This map shows the geographic impact of Jason Lazarou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason Lazarou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason Lazarou more than expected).

Fields of papers citing papers by Jason Lazarou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jason Lazarou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason Lazarou. The network helps show where Jason Lazarou may publish in the future.

Co-authorship network of co-authors of Jason Lazarou

This figure shows the co-authorship network connecting the top 25 collaborators of Jason Lazarou. A scholar is included among the top collaborators of Jason Lazarou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jason Lazarou. Jason Lazarou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
#WorkIndexed citations
1 54
2 0
3 0
4 10
5
Patients: A Meta-analysis of Prospective Studies Incidence of Adverse Drug Reactions in Hospitalized
1
6
Incidence of Adverse Drug Reactions in Hospitalized Patients: A Meta-Analysis of Prospective Studiesbreakdown →
483
7
Incidence of Adverse Drug Reactions in Hospitalized Patientsbreakdown →
3364

About Jason Lazarou

Jason Lazarou is a scholar working on Toxicology, Geriatrics and Gerontology and Family Practice, having authored 7 papers that have together received 3.9k indexed citations. Recurring topics across this work include Pharmaceutical Practices and Patient Outcomes (3 papers), Pharmacovigilance and Adverse Drug Reactions (3 papers) and Pharmaceutical studies and practices (2 papers). The work is most often cited by research in Toxicology (1.4k citations), Geriatrics and Gerontology (1.3k citations) and Pharmacology (870 citations). Jason Lazarou has collaborated with scholars based in Canada and United States. Frequent co-authors include Bruce Pomeranz, Paul Corey, Alejandro A. Rabinstein, Maxwell S. Damian, Romergryko G. Geocadin, Michel Torbey, Eelco F. M. Wijdicks, José I. Suárez, Stephan A. Mayer and Richard Dubinsky. Their work appears in journals such as JAMA, Neurology and Medical Teacher.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026